Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV2 COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04647734
What this trial is testing

The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19

Who this might be right for
COVID-19, SARS-CoV2
Rigshospitalet, Denmark 28
Testing effectiveness (Phase 2)Study completedNCT05576623
What this trial is testing

Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

Who this might be right for
COVID-19Vaccines
Cellid Co., Ltd. 320
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Not applicableUnknownNCT04719208
What this trial is testing

[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse

Who this might be right for
Covid19
Augusta University 60
Early research (Phase 1)UnknownNCT04619290
What this trial is testing

Outpatient Treatment With CoVid-19 With Prexablu

Who this might be right for
Sars Cov 2
Hospital Reg. Lic. Adolfo Lopez Mateos 46
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Not applicableStudy completedNCT04905823
What this trial is testing

Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)

Who this might be right for
Type 1 Diabetes
Paolo Fiorina, MD 600
Testing effectiveness (Phase 2)Study completedNCT05205096
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Not applicableStudy completedNCT04810117
What this trial is testing

Monitoring the IgG/IgM Antibodies in COVID-19 Patients

Who this might be right for
COVID-19 Infections
University of Sargodha 373
Not applicableStudy completedNCT05054218
What this trial is testing

COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients

Who this might be right for
Covid19SARS-CoV2 Infection
H. Lee Moffitt Cancer Center and Research Institute 336
Testing effectiveness (Phase 2)Ended earlyNCT05122182
What this trial is testing

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
University of Sydney 49
Not applicableStudy completedNCT05293379
What this trial is testing

Prospective, Multicenter Study Assessing a Screening Campaign for Cardiovascular Diseases Risk Factors During SARS-CoV-2 Epidemic

Who this might be right for
Health BehaviorCardiovascular DiseasesCardiovascular Morbidity
Elsan 2,400
Not applicableEnded earlyNCT05142540
What this trial is testing

Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines

Who this might be right for
Anti-SARS-CoV-2 Antibody Response
Medical University of Graz 140
Early research (Phase 1)WithdrawnNCT04371640
What this trial is testing

Sirolimus in COVID-19 Phase 1

Who this might be right for
SARS-CoV-2Covid-19
Walter K. Kraft
Testing effectiveness (Phase 2)Study completedNCT04312997
What this trial is testing

The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection

Who this might be right for
COVID-19
Pulmotect, Inc. 101
Not applicableStudy completedNCT02788903
What this trial is testing

A Patient-Centered PaTH to Addressing Diabetes

Who this might be right for
ObesityDiabetesCovid19
Milton S. Hershey Medical Center 2,622,164
Not applicableStudy completedNCT04906850
What this trial is testing

Evaluation of the New Variant 501Y.V2 of COVID-19

Who this might be right for
Covid19
Centre Hospitalier Régional Metz-Thionville 250
Testing effectiveness (Phase 2)Study completedNCT04847050
What this trial is testing

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Who this might be right for
Solid Tumor MalignancyHematologic MalignancyLeukemia+2 more
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT05648110
What this trial is testing

Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 3,882
Not applicableUnknownNCT04479982
What this trial is testing

Microbial Infection and AMR in Hospitalized Patients With Covid 19

Who this might be right for
Covid19
Assiut University 70
Next Page